Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 15 studies | 26% ± 13% | |
| astrocyte | 12 studies | 42% ± 18% | |
| oligodendrocyte precursor cell | 10 studies | 37% ± 17% | |
| microglial cell | 10 studies | 30% ± 12% | |
| oligodendrocyte | 10 studies | 36% ± 13% | |
| GABAergic neuron | 8 studies | 39% ± 20% | |
| glutamatergic neuron | 8 studies | 42% ± 23% | |
| macrophage | 7 studies | 31% ± 9% | |
| adipocyte | 7 studies | 29% ± 7% | |
| epithelial cell | 6 studies | 35% ± 14% | |
| interneuron | 6 studies | 50% ± 21% | |
| amacrine cell | 6 studies | 29% ± 9% | |
| retina horizontal cell | 6 studies | 24% ± 9% | |
| fibroblast | 6 studies | 24% ± 7% | |
| retinal bipolar neuron | 5 studies | 26% ± 8% | |
| myeloid cell | 5 studies | 22% ± 7% | |
| retinal rod cell | 5 studies | 17% ± 2% | |
| dendritic cell | 5 studies | 20% ± 3% | |
| endothelial cell of lymphatic vessel | 5 studies | 23% ± 5% | |
| pericyte | 5 studies | 19% ± 4% | |
| neuron | 4 studies | 41% ± 21% | |
| retinal cone cell | 4 studies | 23% ± 3% | |
| type I pneumocyte | 4 studies | 23% ± 8% | |
| smooth muscle cell | 4 studies | 24% ± 3% | |
| classical monocyte | 3 studies | 20% ± 4% | |
| hematopoietic precursor cell | 3 studies | 20% ± 4% | |
| GABAergic interneuron | 3 studies | 32% ± 7% | |
| granule cell | 3 studies | 32% ± 5% | |
| retinal ganglion cell | 3 studies | 27% ± 8% | |
| ciliated cell | 3 studies | 30% ± 11% | |
| lymphocyte | 3 studies | 20% ± 3% | |
| Mueller cell | 3 studies | 30% ± 4% | |
| GABAergic amacrine cell | 3 studies | 29% ± 9% | |
| OFF-bipolar cell | 3 studies | 25% ± 6% | |
| ON-bipolar cell | 3 studies | 29% ± 6% | |
| glycinergic amacrine cell | 3 studies | 26% ± 4% | |
| rod bipolar cell | 3 studies | 31% ± 10% | |
| basal cell | 3 studies | 29% ± 17% | |
| monocyte | 3 studies | 25% ± 3% | |
| myofibroblast cell | 3 studies | 20% ± 3% | |
| alveolar macrophage | 3 studies | 30% ± 8% | |
| goblet cell | 3 studies | 33% ± 12% | |
| transit amplifying cell | 3 studies | 33% ± 21% | |
| mucus secreting cell | 3 studies | 21% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2008.10 | 1442 / 1445 | 100% | 12.97 | 183 / 183 |
| prostate | 100% | 3071.63 | 245 / 245 | 99% | 9.25 | 497 / 502 |
| pancreas | 100% | 2084.28 | 328 / 328 | 99% | 10.37 | 176 / 178 |
| breast | 100% | 2566.28 | 459 / 459 | 98% | 11.91 | 1100 / 1118 |
| lung | 98% | 2032.66 | 567 / 578 | 99% | 9.62 | 1149 / 1155 |
| thymus | 100% | 4986.98 | 653 / 653 | 98% | 9.65 | 590 / 605 |
| brain | 98% | 1602.06 | 2590 / 2642 | 99% | 8.61 | 699 / 705 |
| bladder | 100% | 2380.10 | 21 / 21 | 97% | 9.56 | 489 / 504 |
| stomach | 100% | 2132.73 | 358 / 359 | 97% | 11.08 | 277 / 286 |
| intestine | 100% | 2694.89 | 965 / 966 | 97% | 10.22 | 509 / 527 |
| adrenal gland | 100% | 2069.46 | 258 / 258 | 96% | 6.40 | 220 / 230 |
| kidney | 100% | 2199.96 | 89 / 89 | 95% | 8.24 | 858 / 901 |
| ovary | 100% | 4183.31 | 180 / 180 | 93% | 5.49 | 402 / 430 |
| uterus | 100% | 3374.46 | 170 / 170 | 92% | 7.37 | 421 / 459 |
| skin | 100% | 1960.52 | 1800 / 1809 | 82% | 5.43 | 388 / 472 |
| liver | 100% | 1350.12 | 226 / 226 | 77% | 4.42 | 312 / 406 |
| spleen | 100% | 3070.98 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.66 | 1 / 1 |
| adipose | 100% | 2150.12 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 1941.35 | 1326 / 1335 | 0% | 0 | 0 / 0 |
| heart | 95% | 1159.50 | 817 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 89% | 5.74 | 40 / 45 |
| muscle | 87% | 697.44 | 701 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 79% | 6.38 | 23 / 29 |
| peripheral blood | 56% | 1091.88 | 522 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 49% | 2.99 | 39 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006325 | Biological process | chromatin organization |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF518A |
| Protein name | Zinc finger protein 518A |
| Synonyms | KIAA0335 ZNF518 |
| Description | FUNCTION: Through its association with the EHMT1-EHMT2/G9A and PRC2/EED-EZH2 histone methyltransferase complexes may function in gene silencing, regulating repressive post-translational methylation of histone tails at promoters of target genes. . |
| Accessions | Q6AHZ1 ENST00000624776.4 [Q6AHZ1-1] ENST00000614149.2 [Q6AHZ1-1] ENST00000316045.10 [Q6AHZ1-1] |